Table 4.
Independent Predictors of all-cause and CVD morality among U.S. adults aged 60 and over, NHANES III (1988–1994)
| All-cause Mortality | CVD Mortality | |||
|---|---|---|---|---|
| Risk Factors | Aged 60–74 | Aged 75 and over | Aged 60–74 | Aged 75 and over |
| NAFLD | 1.23 (1.07–1.42)† | 1.12 (0.97–1.29) | 1.20 (0.95–1.52) | 1.07 (0.90–1.26) |
| Male | 1.41 (1.20–1.65)† | 1.55 (1.30–1.84)† | 1.50 (1.20–1.87)† | 1.51 (1.21–1.87)† |
| Smoker | 2.01 (1.70–2.38)† | 1.27 (0.91–1.77) | 2.09 (1.61–2.71)† | 1.11 (0.66–1.87) |
| Hypertension | 1.45 (1.27–1.67)† | 1.23 (1.01–1.51)† | 1.60 (1.26–2.03)† | 1.24 (0.97–1.60) |
| Hyperlipidemia | 0.96 (0.81–1.13) | 1.01 (0.81–1.25) | 1.35 (1.01–1.81)† | 1.21 (0.88–1.66) |
| Advanced fibrosis | 1.53 (1.21–1.93)† | 1.43 (1.25–1.63)† | 1.27 (0.88–1.82) | 1.37 (1.15–1.64)† |
| History of CVD | 2.00 (1.74–2.31)† | 1.17 (0.94–1.46) | 3.59 (2.86–4.49)† | 1.59 (1.32–1.91)† |
| History of cancer | 1.49 (1.24–1.78)† | 1.15 (0.99–1.33) | 1.44 (1.08–1.94)† | 1.06 (0.90–1.25) |
NAFLD was defined as a US FLI score of ≥30 in the absence of any other cause of chronic liver disease
Advance Fibrosis was defined as a NFS of ≥0.676
†p < .05